Torren Management
RVMD icon

Torren Management’s Revolution Medicines RVMD Stock Holding History

Torren Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.18K Hold
35
– – ﹤0.01% 267
2026
Q2 		$6.56K Hold
35
– – ﹤0.01% 272
2026
Q1 		$3.4K Sell
35
-381
-92% -$38.5K ﹤0.01% 408
2025
Q4 		$33.1K Buy
+416
New +$27.3K 0.02% 448

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Torren Management's RVMD Position: Q3 2026 in Review

Torren Management held its Revolution Medicines (RVMD) position steady in Q3 2026 at 35 shares worth $7.18K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Torren Management first reported a position in RVMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $33.1K in Q4 2025. 405 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Torren Management held 35 shares of Revolution Medicines worth $7.18K as of Q3 2026.
  • Torren Management left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up ﹤0.01% of Torren Management's portfolio in Q3 2026, its #267 holding.
  • Torren Management first reported a position in Revolution Medicines in Q4 2025 and has held it in 4 quarters since.
  • Torren Management's Revolution Medicines position peaked at $33.1K in Q4 2025.
  • 405 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.